Cipla eyes weight management foray: CEO

Cipla, a prominent drug manufacturer based in Mumbai, is set to enter the weight management market in India, according to MD and Global CEO Umang Vohra's FY25 annual report. The company is also focusing on expanding its influence within the central nervous system therapeutic area, aiming to strengthen its overall market position.
Cipla eyes weight management foray: CEO
Representative image
NEW DELHI: Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra said in the company's annual report for FY25. The Mumbai-based company is also strengthening its presence in the central nervous system therapeutic area, he said.
End of Article
Follow Us On Social Media